QUAY Life Sciences Inc. is a strategic public relations firm that is positioned to answer the unique needs of the life sciences community. With unparalleled knowledge and experience assisting the life sciences community, QUAY Life Sciences Inc. provides strategic communications services to biotechnology, health, research and life sciences industries. Our skilled team and comprehensive network allows QUAY to provide organizations with services that support each growth phase of their operation. From new companies to intermediate and mature organizations, we work in partnership with our clients to provide the right services at the right time. Our flexible approach provides customized solutions, strategies and tools, designed to help clients achieve their growth and operational objectives.

Network Immunology Inc. is a vaccine company. The company’s focus is to commercialize a preventive HIV vaccine invented in 2005 by Dr. Geoffrey W. Hoffmann, the President and CEO of the company. The Network Immunology vaccine is for HIV negative persons. The technology is based on a theory of AIDS pathogenesis developed by Dr. Hoffmann and published in 1994 in Cell Biology and Immunology. A key postulate of the theory was validated in a paper published in 2002 in Nature.